Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-05-27 @ 7:00 AM
Study NCT ID:
NCT01414205
Status:
COMPLETED
Last Update Posted:
2017-04-17
First Post:
2011-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GAO4768g
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None